Subsequent risk of cancer among women with a history of placental abruption

References

• Ananth CV, Keyes KM, Hamilton A. An international contrast of rates of placental abruption: an age-period-cohort analysis. PLoS One. 2015;10:e0125246.
   PubMed Web of Science ®Google Scholar
• Tikkanen M, Riihimäki O, Gissler M, et al. Decreasing incidence of placental abruption in Finland during 1980-2005. Acta Obstet Gynecol Scand. 2012;91:1046–1052.
   PubMed Web of Science ®Google Scholar
• Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. 2006;108:1005–1016.
   PubMed Web of Science ®Google Scholar
• Ray JG, Vermeulen MJ, Schull MJ, et al. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797–1803.
   PubMed Web of Science ®Google Scholar
• Signore C, Mills JL, Qian C, et al. Circulating angiogenic factors and placental abruption. Obstet Gynecol. 2006;108:338–344.
   PubMed Web of Science ®Google Scholar
• Tikkanen M, Stenman U-H, Nuutila M, et al. Failure of second trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption. Prenat Diagn. 2007;27:1143–1146.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195:1557–1563.
   PubMed Web of Science ®Google Scholar
• Riihimäki O, Paavonen J, Luukkaala T, et al. Mortality and causes of death among women with a history of placental abruption. Acta Obstet Gynecol Scand. 2017;96:1315–1321.
   PubMed Web of Science ®Google Scholar
• DeRoo L, Skjaerven R, Wilcox A, et al. Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden. Eur J Epidemiol. 2016;31:501–511.
   PubMed Web of Science ®Google Scholar
• Jónsdottir LS, Arngrímsson R, Geirsson RT, et al. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand. 1995;74:772–776.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, et al. Pre–eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.
   PubMed Web of Science ®Google Scholar
• Innes KE, Byers TE. First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer. 2004;112:306–311.
   PubMed Web of Science ®Google Scholar
• Nechuta S, Paneth N, Velie EM. Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control. 2010;21:967–989.
   PubMed Web of Science ®Google Scholar
• Opdahl S, Romundstad PR, Alsaker MDK, et al. Hypertensive diseases in pregnancy and breast cancer risk. Br J Cancer. 2012;107:176–182.
   PubMed Web of Science ®Google Scholar
• Pacheco NLP, Andersen A-MN, Kamper-Jørgensen M. Preeclampsia and breast cancer: the influence of birth characteristics. Breast. 2015;24:613–617.
   PubMed Web of Science ®Google Scholar
• Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand. 2011;90:140–149.
   PubMed Web of Science ®Google Scholar
• Terry MB, Perrin M, Salafia CM, et al. Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol. 2007;165:1007–1014.
   PubMed Web of Science ®Google Scholar
• Tikkanen M, Hämäläinen E, Nuutila M, et al. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption. Prenat Diagn. 2007;27:240.
   PubMed Web of Science ®Google Scholar
• Gissler M, Shelley J. Quality of data on subsequent events in a routine Medical Birth Register. Med Inform Internet Med. 2002;27:33–38.
   PubMed Web of Science ®Google Scholar
• Keskimäki I, Aro S. Accuracy of data on diagnoses, procedures and accidents in the Finnish Hospital Discharge Register. Int J Health Sci. 1991;2:15–21.
   Google Scholar
• Pukkala E, Engholm G, Højsgaard Schmidt LK, et al. Nordic Cancer Registries – an overview of their procedures and data comparability. Acta Oncol. 2018;57:440–455.
   PubMed Web of Science ®Google Scholar
• Tikkanen M, Luukkaala T, Gissler M, et al. Decreasing perinatal mortality in placental abruption. Acta Obstet Gynecol Scand. 2013;92:298–305.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Smulian JC, Vintzileos AM. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol. 1999;93:622–628.
   PubMed Web of Science ®Google Scholar
• Tikkanen M, Nuutila M, Hiilesmaa V, et al. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand. 2006;85:700–705.
   PubMed Web of Science ®Google Scholar
• Warren GW, Cummings KM. Tobacco and lung cancer: risks, trends, and outcomes in patients with cancer. Am Soc Clin Oncol Educ Book. 2013;33:359–364.
   Google Scholar
• Tikkanen M, Surcel HM, Bloigu A, et al. Self-reported smoking habits and serum cotinine levels in women with placental abruption. Acta Obstet Gynecol Scand. 2010;89:1538–1544.
   PubMed Web of Science ®Google Scholar
• Richardson BE, Hulka BS, Peck JLD, et al. Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol. 1998;148:719–727.
   PubMed Web of Science ®Google Scholar
• Yaron Y, Cherry M, Kramer R, et al. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol. 1999;181:968–974.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Wapner RJ, Ananth S, et al. First-trimester and second-trimester maternal serum biomarkers as predictors of placental abruption. Obstet Gynecol. 2017;129:465–472.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Vintzileos AM. Ischemic placental disease: epidemiology and risk factors. Eur J Obstet Gynecol Reprod Biol. 2011;159:77–82.
   PubMed Web of Science ®Google Scholar
• Pukkala E, Andersen A, Berglund G, et al. Nordic biological specimen banks as basis for studies of cancer causes and control – more than 2 million sample donors, 25 million person years and 100 000 prospective cancers. Acta Oncol. 2007;46:286–307.
   PubMed Web of Science ®Google Scholar
• Troisi R, Bjørge T, Gissler M, et al. The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. J Intern Med. 2018;283:430–445.
   PubMed Web of Science ®Google Scholar
• Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet Gynecol. 1988;72:108–112.
   PubMed Web of Science ®Google Scholar
• Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105:239–245.
   PubMed Web of Science ®Google Scholar
• Sund R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand J Public Health. 2012;40:505–515.
   PubMed Web of Science ®Google Scholar
• Gissler M, Haukka J. Finnish health and social welfare registers in epidemiological research. Nor J Epidemiol. 2009;14:1–8.
   Google Scholar